Where can I get medical weight loss treatment in the United States?
Where can I get medical weight loss treatment in the United States?
Begin with the provider-finding route that fits your location
You can find physician-supervised medical weight-loss treatment through an obesity-medicine directory, a primary-care referral, a local clinic, or a virtual program that serves your state. Your location, preferred visit format, and need for ongoing follow-up should shape the first shortlist.
The Obesity Medicine Association provider directory lets you search by city, state, or ZIP code for a clinician with specialized obesity-medicine training. Your primary healthcare provider may also be able to refer you to a bariatric healthcare provider. These routes help you locate possible clinicians; they do not replace your own screening of the care model.
Provider credentials can give you another way to narrow the list. You can look for ABOM Diplomates; they have completed at least 60 hours of obesity-specific education and passed the American Board of Obesity Medicine certification exam. Obesity Medicine Association Fellows have completed at least 75 hours of advanced training in obesity medicine. Those labels describe training, so ask separately about evaluation, prescribing, monitoring, and follow-up.
Keep your first screen focused on location, clinical oversight, continuity, and payment structure. Start with several possible providers, then remove any option that cannot explain where you may receive care or who will manage treatment.
Before contacting a provider, write down the state where you will usually receive care, whether you need in-person visits, whether travel is realistic, and what kind of follow-up you expect. A provider that looks suitable in a national search may not serve your state or may require visits at a location you cannot reach.
Use the directory or referral to answer one practical question first: can this clinician offer the kind of care you need in the place where you will be located? If the answer is unclear, keep the provider on a research list rather than treating it as an available treatment option.
Shortlist local, virtual, and hybrid care options
Local, virtual, and hybrid care differ in where required visits, testing, and follow-up take place. A local clinic may suit you if you want in-person examinations or laboratory work. A virtual program may reduce travel, but you still need to establish that the provider serves your state and can provide the relevant care under applicable rules.
A separate greater Miami program illustrates another hybrid model: it requires an initial consultation, baseline labs, and periodic in-person follow-up at its Surfside clinic, while telehealth follow-ups are available between visits. That arrangement belongs to that program and is not a national standard.
Use these questions to narrow your list:
- Does the provider accept patients who live in your state?
- Can the first evaluation happen virtually, or must you attend in person?
- Are physical examinations, baseline labs, or later visits required on site?
- How will you reach the clinician between scheduled visits?
- What happens if you move, travel, or need follow-up outside the usual service area?
- Can the provider continue care if the visit format changes?
Choose a local, virtual, or hybrid option only after the provider explains the visit requirements and geographic boundary that apply to you.
Access is more than the first appointment. Consider the practical pattern over time: how often you may need to attend in person, whether laboratory work requires a separate trip, and how you would communicate about a treatment question between visits. If you live far from a clinic, a program that requires periodic in-person care may be less workable than it first appears.
Keep two options separate in your notes: where the first consultation occurs and where continuing care occurs. A virtual intake does not necessarily mean every later step can happen online.

Check whether the first visit is a real clinical evaluation
A medical weight-loss evaluation may include a medical history review, physical examination, and possibly lab tests. During a first virtual visit, a clinician may ask about your health history, symptoms, past treatments, and goals before recommending a personalized care plan and follow-ups.
One virtual-care program describes a first visit that runs about 30 minutes. That duration describes one program, not a required length for every clinic. The more useful question is whether the clinician has enough information to discuss your health and treatment options rather than treating medication as an isolated purchase.
Ask what the first visit covers before you book it:
- Which parts of your medical history and current symptoms will the clinician review?
- Will the clinician ask about previous weight-management treatments and your goals?
- Is a physical examination required, and where would it occur?
- Are laboratory tests possible or indicated based on your history?
- How will the clinician decide whether medication belongs in your plan?
- What follow-up is included after the initial evaluation?
Prepare a current list of prescription medicines, over-the-counter medicines, vitamins, supplements, relevant diagnoses, previous treatment experiences, and questions about your goals. Clear information gives the clinician a more useful starting point.
An evaluation connects the information collected to a clinical decision. A medical history review can help identify health conditions affecting weight, while a physical examination or laboratory testing may add information when clinically appropriate. Laboratory testing may be part of an evaluation, but it is not universal, so the absence of a lab order alone does not establish that a provider skipped an important step. A provider should be able to explain what information it needs and how the findings would shape the care discussion or follow-up. That explanation helps distinguish a clinician-led assessment from a form that only gathers enough information to route a medication request.
A consultation route that cannot explain its evaluation process leaves you without a clear basis for an individualized treatment discussion. A medical weight-loss clinic may create a tailored plan after evaluation that includes dietary changes, exercise, behavioral therapy, and medication such as semaglutide, liraglutide, or tirzepatide.
Do not treat a screening form, a medication questionnaire, or a short administrative call as the same thing as a clinician evaluation. Ask what happens next and who makes the clinical decision before you proceed.
Verify monitoring, prescribing, and continuity before enrolling
Continuity means knowing who responds when your symptoms change, a medicine is unavailable, your medical history changes, or a follow-up test needs attention.
Ask these questions before enrolling:
- Who reviews your response and tolerability?
- How do you report a side effect between appointments?
- When are laboratory results or medication changes reviewed?
- Who can change, continue, or discontinue a prescription when medically appropriate?
- What happens if the original clinician is unavailable?
A provider should be able to describe the route from evaluation to follow-up without reducing care to a single prescription.
Monitoring has a practical purpose beyond documenting that a prescription was issued. A follow-up review can give the clinician a point at which to consider treatment response, tolerability, medical-history changes, medication changes, and laboratory results when indicated. A continuity plan should also identify how a patient reaches the care team between scheduled visits and what happens when the original clinician is unavailable. Ask a provider to describe the response to a new side effect, a changed medication list, and a needed prescription decision before enrolling. Clear answers show whether follow-up is an operating part of care rather than an optional message channel. The coverage percentages in the infographic do not establish an individual patient’s insurance benefit. Patients should verify medication coverage and payment terms with the insurer and the provider.
Ask how medication fits into the broader plan
One clinical case involved adding semaglutide 0.25 mg after the first visit for a 45-year-old man with uncontrolled diabetes who was already using insulin; continuous glucose monitoring also began after that visit. That case illustrates why medication decisions depend on health conditions and existing medicines. It does not provide a dose for you.
Wegovy semaglutide injection 2.4 mg is indicated with a reduced-calorie diet and increased physical activity for the populations and purposes described in its approved labeling. Ask the clinician which indication, medication, and accompanying plan apply to your situation.
Bring these questions to a consultation:
- What information determines whether semaglutide or tirzepatide is appropriate?
- What non-medication parts of the metabolic plan will accompany treatment?
- How will response, tolerability, medical-history changes, and laboratory results be reviewed?
- What side effects should you report, and how should you contact the care team?
- How will the plan address maintenance and continuity if treatment changes?
- Which medicines, supplements, or health conditions could affect the discussion?
A provider should connect the medication discussion to your health history and follow-up plan. Do not choose solely from a medication name or an advertised access route.
Medication choice and medication safety are separate questions. Both tirzepatide and semaglutide have been shown effective for weight loss, but that evidence does not determine which option is appropriate for an individual. Wegovy may affect how some medicines work, and Wegovy slows stomach emptying, which can affect medicines that need to pass through the stomach quickly. A consultation should therefore include the complete medicine and supplement list before the clinician discusses a medication plan. Ask what information would change the recommendation and how the clinician would revisit that decision if health conditions or other medicines change.
Coverage percentages for injectable tirzepatide and oral semaglutide describe plan-level coverage, not whether a particular patient’s insurer covers a medicine. Verify medication and insurance terms with the provider and insurer before treating coverage data as part of an individual treatment plan.

Confirm state access and the consultation path
State access determines whether a virtual consultation can lead to treatment. Authorized providers can prescribe controlled substances via telehealth if they meet certain criteria. Ask the clinic which state-specific requirements apply to your location and visit type. This general telehealth rule does not establish that every provider can treat you throughout the United States.
Ask whether the clinician is authorized to treat you where you are located during the visit, whether an in-person examination or laboratory appointment is required, and how follow-up will work if you are temporarily in another state. Do not assume that a virtual appointment makes every provider available nationwide.
A consultation path should tell you what happens after you submit an inquiry. One provider page directs prospective patients to contact the practice or schedule an appointment online for more information. That is an example of a contact route, not a statement that every clinic uses the same process.
Before you submit information, ask whether the initial contact is an administrative screening or a clinician visit, what records you should have ready, and whether the appointment begins an evaluation or only collects your contact details. Choose a route that gives you a clear next step without implying access before a clinician reviews your circumstances.
Keep the consultation route separate from the treatment decision. Have your location, medication list, relevant health history, prior treatment information, and questions ready, but do not assume that submitting a form means you have been accepted for care. The clinician still needs to determine whether a plan is appropriate and what monitoring it requires.
Telehealth access also has an information boundary. A provider may explain that authorized clinicians can prescribe through telehealth when certain criteria are met, but that general statement does not establish that the provider serves your state or that your visit qualifies. Ask the clinic to identify the location rule and visit requirement that apply to your circumstances before treating an online intake as access to care. Keep the provider’s current service-area statement with your consultation notes so you can recheck it if your location changes.
Compare payment factors before choosing
Medical weight-loss treatment has no single nationwide typical total. Provider-reported examples illustrate the range without establishing a national benchmark: one Phoenix practice reports total program costs of $100 to upwards of $1,000, while another source reports total costs of $1,000 to $5,000 and monthly fees of $100 to $500. The final amount can vary with the care plan, medication, visits, and payment arrangement, and medication may be priced separately. Ask for a complete breakdown of the consultation, program or membership services, medication, laboratory work, follow-up visits, supplies, and any services billed separately. Insurance coverage for weight-loss medication varies by provider and plan; a clinic may be in-network with some major carriers, and certain services may be covered.
Do not compare providers using only the first advertised figure or the medication name. Ask whether the quoted arrangement assumes insurance, self-pay, a particular medication, a particular pharmacy, or a particular visit schedule. Separate the care plan from the medication arrangement so you know which parts may change independently.
Published cost ranges on individual provider pages do not establish a current national typical cost for medical weight-loss treatment. A provider-specific quote is more useful when it identifies the consultation, recurring program or membership services, medication, laboratory work, follow-up, insurance contribution, and self-pay responsibility separately. Ask each clinic to state which items are included, which are billed separately, and which circumstances can change the total. Record the answers using the same categories for every provider so that a lower initial figure is not mistaken for a lower overall obligation. Recheck these terms before enrolling because treatment duration, medication choice, visit frequency, insurance terms, and payment method can change the amount you are responsible for.
Duration can change your overall payment obligations. Programs lasting several months to a year may include regular check-ins, ongoing counseling, and possibly multiple rounds of treatment. Ask how the length of care affects recurring payments, follow-up visits, medication arrangements, and any services that remain separate.
The selected Phoenix provider page says that final payment requirements depend on program length, included services, and individual patient needs. That statement applies to the cited provider page, not to every clinic in the United States. Treat it as a reminder to request the full structure for the provider you are considering.
Use a written comparison checklist before choosing:
- What must you pay before the first clinical evaluation?
- Which visits, messages, laboratory services, and follow-ups are included?
- Is medication separate, and can the medication or pharmacy change your total obligation?
- What does the clinic submit to insurance, and what remains your responsibility?
- What happens if treatment is delayed, changed, discontinued, or transferred?
- Are there recurring obligations, cancellation terms, or services outside the program?
Ask for the complete payment terms in plain language. Compare the full care pathway, not only the first contact or the medication name.
Contact Misra Wellness about its California and New York care options.
You can contact Misra Wellness through our contact form. Use that route to begin a practice-specific conversation about location, evaluation, monitoring, follow-up, and the scope of care you need.
The national search context does not mean that Misra Wellness provides treatment in every state.
Confirm current eligibility, the consultation route, and the ongoing scope of care with Misra Wellness before treating the practice as an available option.
Pause and seek qualified help for concerning reactions or conditions
Some conditions and medicines need a specific clinical discussion. The interaction between GLP-1 receptor agonists and symptoms of some gastrointestinal conditions is unclear, but interaction is considered likely because of GLP-1 effects on gastrointestinal functions. The effect of GLP-1 receptor agonists in heart failure is unclear; use in heart failure with reduced ejection fraction warrants caution because of potential risks of worsening heart-failure events and arrhythmias. Tell the prescriber about these conditions rather than deciding independently whether treatment is appropriate.
In a trial of patients with type 2 diabetes and BMI at least 27 kg/m², hypoglycemia below 54 mg/dL was reported in 4.2% of Zepbound-treated patients and 1.3% of placebo-treated patients. Among Zepbound-treated patients, hypoglycemia occurred in 10.3% of those taking a sulfonylurea compared with 2.1% of those not taking a sulfonylurea. These percentages describe the named trial groups and conditions; they do not predict your personal risk.
Safety questions belong before enrollment as well as after treatment begins. A qualified clinician should review the medicines, supplements, and health conditions you disclose before discussing whether a GLP-1 medicine belongs in a plan. Serious reactions to GLP-1 receptor agonists were rare in clinical trials, but serious side effects can occur among the hundreds of thousands of patients using these drugs. Prompt qualified help is appropriate for a serious or rapidly worsening reaction; do not rely on an online intake form to manage an urgent problem.
An ECRI review examined 2 systematic reviews and 6 real-world studies, each including 500 or more patients, plus recommendations from 5 evidence-based clinical guidelines and 4 expert consensus documents. The practical takeaway is to choose care that includes risk discussion, monitoring, and a way to address side effects.
Start with a qualified clinician’s evaluation, provide a complete medication and health history, and contact the prescriber promptly about concerning changes. Follow urgent product instructions when they direct immediate medical attention and discontinuation, such as the hypersensitivity instruction for Zepbound. Use local emergency services for a life-threatening emergency.

Request the next informed consultation
Your next step is a short screening decision: confirm that the provider serves your location, offers a genuine clinical evaluation, explains monitoring and follow-up, and gives you complete payment terms before enrollment. Prepare your location, health history, medicine list, prior treatment information, and questions about continuity. A qualified clinician decides whether an individual treatment is suitable after reviewing your health history, medicines, and current needs.
If Misra Wellness fits your location and the care model you are seeking, request a consultation. No appointment time is reserved by the request.
What should I verify before choosing a medical weight-loss provider?
Can a virtual medical weight-loss provider treat me if I am traveling or living in another state?
Not necessarily. Eligibility depends on where you are located during care, the provider’s service area, and applicable state requirements. Ask whether the clinician may treat you in your state, whether in-person examinations or laboratory visits are required, and how follow-up works if you travel or move.
What should I bring to a medical weight-loss consultation?
Prepare your current prescription and nonprescription medication list, vitamins and supplements, relevant diagnoses, previous treatment history, symptoms, and goals. This information helps the clinician assess your health, discuss whether medication is appropriate, and plan monitoring or follow-up.
How can I tell whether a clinic will continue care after prescribing a GLP-1 medication?
Ask who reviews treatment response and tolerability, how you report side effects between visits, when laboratory results and medication changes are reviewed, and who can adjust, continue, or discontinue treatment when medically appropriate. A suitable care pathway should explain ongoing monitoring rather than stopping at the prescription.
What should I do if I have a concerning reaction while using a GLP-1 medication?
Contact the prescriber promptly about concerning changes and seek immediate qualified medical help for a serious or rapidly worsening reaction. For a suspected hypersensitivity reaction while using Zepbound, the product guidance says to seek medical attention promptly and discontinue use.
Ready for a real plan?
Work directly with Dr. Misra — no insurance, no rush.
Misra Wellness is a virtual-first Direct Primary Care practice serving California and New York. Book a meet & greet to see if we're the right fit.
Book a meet & greet